Durability, Behavior, and Tolerability of 5 Hyaluronidase Products.
Abstract
[BACKGROUND] Hyaluronic acid (HA) dermal fillers are commonly used in cosmetic dermatology. Due to differences in their physical characteristics, HA fillers demonstrate different sensitivity to degradation by hyaluronidase (Hase) because of HA concentration and differences in cross-linking. Similarly, there are differences in the activity of Hase products depending on source and concentration.
[OBJECTIVE] The primary objective was to demonstrate the differences in potency and activity of 5 Hase products when used to degrade 5 different HA products using a human in vivo model.
[MATERIALS AND METHODS] The study subject was a healthy, consenting adult woman scheduled to undergo abdominoplasty. Skin to be excised was injected with 0.1 to 0.2 mL of each filler (10 injections each) leaving a visible lump. Immediately afterward, the HA lumps were injected with 4 IU of each Hase product every 2 minutes until the HA lumps were no longer visible or palpable. This procedure was repeated after 30 days. Injected tissues were excised after abdominoplasty for histological analysis.
[RESULTS] The 5 Hase products displayed a wide range of doses and times required to completely degrade the 5 HA products ranging from <2 to >16 minutes.
[CONCLUSION] Cosmetic practitioners should familiarize themselves with differences in HA and Hase products.
[OBJECTIVE] The primary objective was to demonstrate the differences in potency and activity of 5 Hase products when used to degrade 5 different HA products using a human in vivo model.
[MATERIALS AND METHODS] The study subject was a healthy, consenting adult woman scheduled to undergo abdominoplasty. Skin to be excised was injected with 0.1 to 0.2 mL of each filler (10 injections each) leaving a visible lump. Immediately afterward, the HA lumps were injected with 4 IU of each Hase product every 2 minutes until the HA lumps were no longer visible or palpable. This procedure was repeated after 30 days. Injected tissues were excised after abdominoplasty for histological analysis.
[RESULTS] The 5 Hase products displayed a wide range of doses and times required to completely degrade the 5 HA products ranging from <2 to >16 minutes.
[CONCLUSION] Cosmetic practitioners should familiarize themselves with differences in HA and Hase products.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 재료 | ha
|
히알루론산 | dict | 8 | |
| 시술 | abdominoplasty
|
복부성형술 | dict | 2 | |
| 시술 | filler
|
필러 주입술 | dict | 1 | |
| 해부 | Skin
|
scispacy | 1 | ||
| 해부 | tissues
|
scispacy | 1 | ||
| 재료 | hyaluronic acid
|
히알루론산 | dict | 1 | |
| 약물 | [BACKGROUND] Hyaluronic acid
|
scispacy | 1 | ||
| 약물 | [OBJECTIVE]
|
scispacy | 1 | ||
| 기타 | Hyaluronidase Products
|
scispacy | 1 | ||
| 기타 | hyaluronidase (
|
scispacy | 1 | ||
| 기타 | human
|
scispacy | 1 |
MeSH Terms
Adult; Antidotes; Dermal Fillers; Dose-Response Relationship, Drug; Female; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Skin
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Choroidal ischemia after self-injection of hyaluronic acid filler.
- Case report of a rare soft tissue tuberculosis in a patient undergoing lipoabdominoplasty.
- What is the potential role of the nonopioid suzetrigine in pain management?
- Intra-articular therapies for synovial joint dysfunction: a comprehensive integrative review.